☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Rare Diseases
Selecta Collaborates with Ginkgo to Develop Therapeutic Enzymes for the Treatment of Orphan and Rare Diseases
October 27, 2021
Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics
February 11, 2021
Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan
August 24, 2020
Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets
June 24, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.